Back to search
FDAFDA · Food and drugs·Recall number Z-0002-2023

Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004 version 5.2.0

Published October 12, 2022 · Recall initiated: September 8, 2022

Summary

FDA records medical device Class I recall Z-0002-2023, published October 12, 2022 and initiated September 8, 2022. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 4 instances; Lot: UDI-DI: 00811505030122 version 5.2.0. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The display screen may become frozen and unresponsive to user input, triggering an alarm that is evidenced by a buzzer sound and flashing red LEDs as a secondary notification. However, as the screen goes blank it does not indicate an alarm condition or respond. This issue leads to temporary cessation of flow of a medication or fluid, requiring immediate intervention by the clinician.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
Domestic distribution to NJ and WI.
Lot
UDI-DI: 00811505030122 version 5.2.0
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Ivenix Infusion System (IIS), LVP Software; LVP-SW-0004 version 5.2.0 recalled?

Yes. FDA published recall Z-0002-2023 on October 12, 2022. Reported hazard: The display screen may become frozen and unresponsive to user input, triggering an alarm that is evidenced by a buzzer sound and flashing red LEDs as a secondary notification. However, as the screen goes blank it does not indicate an alarm condition or respond. This issue leads to temporary cessation of flow of a medication or fluid, requiring immediate intervention by the clinician.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone